1. Home
  2. GOGO vs RLAY Comparison

GOGO vs RLAY Comparison

Compare GOGO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

HOLD

Current Price

$7.10

Market Cap

941.0M

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOGO
RLAY
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
1.0B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
GOGO
RLAY
Price
$7.10
$7.69
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$14.00
$16.00
AVG Volume (30 Days)
1.5M
2.1M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$817,729,000.00
$8,355,000.00
Revenue This Year
$107.81
$20.47
Revenue Next Year
$0.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
102.05
N/A
52 Week Low
$6.20
$1.78
52 Week High
$16.82
$8.36

Technical Indicators

Market Signals
Indicator
GOGO
RLAY
Relative Strength Index (RSI) 39.71 58.73
Support Level $6.99 $7.23
Resistance Level $7.19 $8.36
Average True Range (ATR) 0.29 0.51
MACD 0.08 0.05
Stochastic Oscillator 35.38 69.18

Price Performance

Historical Comparison
GOGO
RLAY

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: